Training activity information
Details
Select, perform and interpret for the investigation of a haematological malignancy to include investigation by:
- Morphology
- Immunophenotyping
- Molecular
- Karyotyping/cytogenetics
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Sample suitability and integrity
- Following local SOPs
- Relevant national and international guidelines
- IQC and EQA
- Maintenance and basic troubleshooting
- Reference intervals
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What background knowledge of different haematological malignancies and the principles of morphology, immunophenotyping, molecular techniques, and cytogenetics is needed?
- What insights do you hope to gain regarding how these different diagnostic modalities contribute to the overall investigation and classification of these cancers?
- What is your current understanding of when and why each of these techniques is used?
- How will you prepare for this activity (e.g., reviewing relevant guidelines, understanding the workflow of each technique)?
- What potential difficulties might you face in selecting appropriate tests, performing them, or interpreting the diverse range of results, and how will you strategize to overcome these?
- How do you feel about undertaking such a complex and multifaceted investigation?
In action
- Based on the initial findings (e.g., morphology), what further investigations are you immediately deciding to perform? What is the rationale behind these choices?
- As results from different investigations become available (e.g., flow cytometry alongside morphology), how are you integrating this information in real-time to refine your interpretation?
- Are you encountering any technical difficulties with any of the testing platforms? How are you troubleshooting these as they occur?
- Are you considering the need for multidisciplinary input at any point during the investigation?
On action
- What were the key clinical features and initial laboratory findings that indicated a potential haematological malignancy?
- What specific morphology, immunophenotyping, molecular, and karyotyping/cytogenetics techniques were selected for this investigation?
- Why were these specific tests chosen? What were the key findings from each of these investigations?
- How did you integrate the results from the different testing modalities to form an overall interpretation?
- Were there any concordant or discordant findings?
- What is the role of each of these investigative techniques (morphology, immunophenotyping, molecular, karyotyping/cytogenetics) in the diagnosis and classification of haematological malignancies?
- How do the results from these different approaches complement each other in providing a comprehensive picture of the disease?
- What are some of the key diagnostic markers or features identified by each technique that are characteristic of different haematological malignancies?
- How are national and international guidelines (e.g., WHO classification) used in the interpretation of these integrated results?
- How will this experience enhance your ability to select appropriate investigations for suspected haematological malignancies?
- How will you improve your skills in interpreting and integrating complex data from multiple laboratory disciplines?
- What resources or guidelines will you use to stay updated on the evolving diagnostic criteria for haematological malignancies?
Beyond action
- Have you been involved in the investigation of other haematological malignancies since this training activity, utilising a range of diagnostic techniques? How did these experiences compare?
- Have you reviewed your reflect-on-action notes for this training activity? Has your understanding of the integrated approach to diagnosing haematological malignancies deepened?
- Can you recall multidisciplinary team (MDT) meetings where the results from morphology, immunophenotyping, molecular, and cytogenetic analyses were discussed in the context of a specific case?
- Have you engaged in discussions with senior colleagues or pathologists about the interpretation of these complex datasets in different types of haematological malignancies?
- Has this training activity enhanced your understanding of the complementary roles of different laboratory techniques in the diagnosis and classification of haematological malignancies?
- Do you now have a better appreciation for the importance of integrating morphological findings with flow cytometric, molecular, and cytogenetic data?
- Has this experience influenced your ability to identify appropriate follow-up tests or investigations based on initial findings? Have the skills developed in this activity, such as critical evaluation of multi-parameter data and understanding diagnostic algorithms, been transferable to other areas of your work?
- How will your experience in the integrated investigation of haematological malignancies prepare you for more complex cases and potential involvement in research or clinical trials?
- Will your ability to understand and interpret these diverse datasets contribute to more accurate and timely diagnoses, ultimately impacting patient care?
- How might this experience support your development in a specialist role focused on haematological oncology diagnostics?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 3 |
Outcome
Perform a range of laboratory and molecular testing techniques to diagnose and monitor treatment of haematological malignancy in the correct clinical context, including the interpretation and reporting of results. |
| # 4 |
Outcome
Interpret and comply with national and international guidelines on the diagnosis and management of haematological cancer. |
| # 7 |
Outcome
Perform quality assurance and control tasks across the range of investigations. |